Background: A systematic literature review of the last 40 years on the research of serum antibodies to Pseudomonas aeruginosa in cystic fibrosis and its utility as a diagnostic tool. Methods: Research papers in English, Portuguese, and Spanish were accessed through electronic databases (PubMed, Medline, LILACS, and SciELO). Results: 26 studies were assessed. ELISA technique was the most commonly used technique to detect serum P. aeruginosa antibodies. The most consistent results were those in which the response against the antigen St-Ag:1-17 was evaluated. The accuracy levels of the ELISA technique remain controversial, but most studies showed a good correlation between antibody titers and microbiological culture. Conclusions: The detection of serum antibodies to P. aeruginosa shows capacity for early detection of this pathogen and potential utility and viability of incorporation in the diagnostic routine of patients with cystic fibrosis.
Introduction
Pseudomonas aeruginosa pulmonary infection is responsible for elevated morbidity and mortality among cystic fibrosis (CF) patients [1, 2] . In childhood, 10 to 30% of these patients are colonized and in adulthood, 80 to 90% are infected with this bacterium. Patients infected with P. aeruginosa generally present a reduction of about 10 years in life expectancy when compared with the non-infected ones [3] .
When chronic infection [4] is established, P. aeruginosa is practically impossible to be eradicated [1, 2] , although, its clearance from the respiratory tract is possible through early intervention with antibiotic therapy, as soon as the pathogen settles in the organism. Thus, early aggressive treatment is recommended, being possible to delay the chronic colonization and progression of the pulmonary disease [5] .
Detection of P. aeruginosa in the diagnostic routine is made mostly through sputum culture -spontaneously expectorated or induced by inhalation of hypertonic saline (3-7%); however, many patients -especially children under 7 years -are incapable of producing an expectorated sputum specimen. BAL, the gold standard, is an option, but it is invasive and usually employed only when there is a compelling reason to obtain a respiratory sample and other approaches have failed. For this reason, oropharyngeal (OP) swabs are used as a surrogate for sputum or BAL fluid specimens in these individuals, sampling the microbial flora of the upper respiratory tract, which is assumed to reflect that of the lower respiratory tract [6] . Despite the good specificity reported for this method, in comparison to BAL culture, it is known that a negative culture from the upper airways does not exclude the presence of P. aeruginosa in the lower airways [7, 8] . Sampling errors during the BAL and the frequent insufficient sample obtained through oropharyngeal swab can lead to false negative results [7] . The difficulty in obtaining representative respiratory specimens from the airways of infants and children indicates the need for the use of methods that can complement or be an alternative to microbiological culture [9] .
The detection of serum antibodies against P. aeruginosa has emerged as a possible auxiliary method to assess the early eradication therapy [10, 11] . Highly sensitive methods for detection of antibodies against several P. aeruginosa antigens may complement the monitoring methods currently used [11] . Positive antibody titer results and culture-negative samples of respiratory secretion should alert health professionals to perform a more thorough search for a probable infection, by repeating the test or by using more sensitive and specific methods. In contrast, increasing antibody levels are associated with a greater likelihood of persistent P. aeruginosa chronic infection [9] . Elevated antibody titers at the time of initial OP culture may be a useful tool for CF clinicians and researchers monitoring patients at risk for subsequent infection. However, their use in routine practice remains controversial [9] .
Thus, the aim of this systematic review was to collect studies published in the last 40 years addressing the detection of serum antibodies to P. aeruginosa and to evaluate its utility for early detection of this bacterium and the diagnostic and prognostic value in CF patients.
Methods
Research papers in English, Portuguese, and Spanish in the period from 1973 to 2013 were reviewed. The search for references was made through electronic database exploration (PubMed, Medline, LILACS and SciELO), using the keywords "Cystic Fibrosis", "Pseudomonas aeruginosa", "serology", and "serum antibodies", and their correspondent translations in varied combinations, from November to August of 2013. In addition, the references of all papers were consulted in the search of new papers to include.
Then, we began the paper selection process, by reviewing titles and abstracts. The first inclusion criterion was the identification of potentially relevant papers, considering those in which the study assessed the utility of serum antibody detection in the diagnostic routine of pulmonary disease. The recuperation criteria for complete papers were the following types of study: cohort, longitudinal, case-control, descriptive, experimental and cross-sectional, whose results addressed such subject. The selection was based on the limits of the compliance of issues in relation to objectives, excluding those in which, despite appearing in the search results, did not address the issue from the diagnostic point of view of serum antibody detection. We also excluded review articles, studies addressing the immune response to P. aeruginosa but not related to CF, or related to CF but without clinical application or applied to the diagnosis and studies not related to the CF pulmonary disease.
Data synthesis

Studies addressed, casuistries and methods used
In the first search, a total of 29 research papers were found, being submitted to a filter process, from which only the papers that could be fully accessed were selected. The review was finished by reading the complete papers and, in the final text, 25 papers were included. The studies were mostly longitudinal [13, 14, 19, 21, 28, 30, 35, 37] and experimental [16, 18, 23, 26, [32] [33] [34] , and there were also prospective [12, 15, 16] , case-control [27] , cohort [20, 23, 29] and cross-sectional studies [21, 30, 36] ; all of them were in English (Table 1 ).
In the last 40 years, a total of 3148 patients were evaluated, aged from 0 to 65 years of age, and seven of the studies did not specify their age range ( Table 2) . With regard to the diagnostic method (Table 3) , the ELISA technique was the most commonly used method (22 studies), followed by CIE (5 studies), Western blot (5 studies), and RIA (one study). Five studies used more than one method. Different antigens were used, being Exotoxin A (ExoA) the most used (13 studies), followed by Elastase (ELA) (10 studies), St-Ag:1-17 (Statens Serum Institute®) (8 studies), Alkaline protease (AP) (8 studies), Lipopolysaccharides (LPS) (3 studies), and other antigens in 8 studies (Table 2 ). Six studies used the M-15 kit (Mediagnost®) -ExoA, ELA, and AP.
Diagnostic and prognostic value
The pioneer studies on serological diagnosis of P. aeruginosa infection in CF patients date from the 70s by Høiby et al. [12] , based on the antibody detection by precipitation tests (precipitins) of CIE. In a 5-year follow-up of 133 patients, high precipitin titers and rapid increase of these were associated with the worst prognostic, which was corroborated by Döring et al. [13] , who found a higher precipitin production when mucoid P. aeruginosa persisted in the lungs, leading to a higher formation of immunocomplexes.
In the 80s, the ELISA technique was included using great antigen diversity. Overall, there was a significant correlation between ELISA and CIE results [13, 16, 18] .
Brett et al. [14] observed higher antibody titers in chronically infected than in intermittent patients, with an overlap between the two groups. However, higher titers against ExoA, ELA, and AP (relative to phospholipase C) were observed among patients colonized/infected with mucoid P. aeruginosa than among patients who only presented non-mucoid P. aeruginosa. Burns et al. [20] searched for IgG antibodies against P. aeruginosa through ExoA ELISA and Western blot for the whole cell antigens. By sputum culture, only 45% of patients would be considered to be infected, while antibody detection elevated this percentage to 97.5%. Da Silva Filho et al. [30] analyzed the serology utility (E-15 kitMediagnost®) for 87 patients, comparing with PCR and culture, including 16 patients with negative culture, 20 intermittently colonized and 51 chronically infected patients. They found that the association of the three methods provided the highest positivity percentage (PCR with the higher one), but had no statistical significance. Weisner et al. [28] studied the utility of ELISA for P. aeruginosa anti-LPS band A antibodies in oral fluids compared with serum samples in patients with positive culture for P. aeruginosa and healthy volunteers. They found significant titers in the oral fluids in 15 of the 17 CF patients and in all serum samples, but in none of the volunteers. Doğru et al. [37] showed significant higher antibody titers against ExoA, ELA and AP in patients colonized with mucoid P. aeruginosa. The antibody presence showed varied values, with ELA antibodies presenting the higher titers.
Early detection of the P. aeruginosa infection
Brett et al. [17] , in another ELISA study (for antibodies against cell wall antigens), observed an enhancement in IgG levels until 24.5 months before the first bacterial isolation in culture. Kronborg et al. [19] showed an increase in the serum IgG, IgM and IgA responses to the lipid A, R-LPS, and S-LPS antigens during the chronic infection course, mainly IgG and IgA. Moss et al. [21] found the presence of antibodies against the TTSS proteins in adult CF patients through Western blot. About 70% patients had anti-PopD IgG, 90% had anti-PopB IgG, and 67% had anti-PcrV IgG. The humoral immune response also showed anti-ExoS IgG in about 33% of the cases, and anti-ExoA IgG in 73% of patients. There were evidences that humoral immune response was early for the TTSS components, during the initial stage of infection, as shown by other two studies [24, 28, 36] , being the response to TTSS antigens earlier than to ExoA and PAO1 cell lysate, and the pathogen being found in a mean time of 21 months before the first isolation in the microbiological culture.
West et al. [22] reported a 15-year longitudinal monitoring of antibody response (IgG, IgM e IgA) against several P. aeruginosa antigens in sera of 68 patients, detecting the bacterium up to 12 months before the first isolation. Significant titers of anti-cell lysate and anti-ExoA antibodies were detected before or simultaneous to the first P. aeruginosa isolation in about 60% of the patients, and antibody titers against ELA were detected until about 40 months after the first isolation.
Pressler et al. [27] followed 89 patients free of infection in a period of 10 years and found 28 patients that acquired chronic infection despite of early antibiotic treatment. This group was compared with 28 patients who did not acquire chronic infection and it was observed that specific P. aeruginosa IgG antibodies were significantly higher in the cases than in the control group until three years before the acquisition of chronic infection, but remained at the initial levels in the control group. Later, Pressler et al. [32] , following 791 patients, found that, out of 381 patients cultured negative for P. aeruginosa, 11 changed status to chronically infected and 24 out of 129 intermittently colonized became chronically infected. The antibody titers in this latter group were significantly higher at the study start and increased significantly during the study period. Elevated levels of specific anti-pseudomonal antibodies showed to be the risk factor for developing chronic infection.
Tramper-Standers et al. [26] , in a longitudinal study, using microbiological culture as reference, monitored the IgG response to ExoA, ELA and AP of 220 patients during three consecutive years, performing serological tests annually. All the three individual serological tests discriminated well between the absence and presence of chronic P. aeruginosa colonization.
In 2010, Hayes et al. [33] published a longitudinal 6-year study that followed 69 children from the CF diagnosis by neonatal screening. They used serology for anti-cell lysate, ExoA and ELA antibodies. By establishing cut-offs according to the age of the patients, they could early identify P. aeruginosa until 2 years before the detection in microbiologic culture.
Anstead et al. [35] , using five antigens and two different ELISA tests, found, in recently P. aeruginosa colonized children, that baseline positive serology was not significantly associated with failure in bacterial eradication with previous treatment for 10 weeks, but seropositivity to AP and ExoA was significantly associated with increased risk of recurrent isolation 60 weeks after eradication. There was no association between baseline seropositivity and time to pulmonary exacerbation.
Antibody titers and clinical status
Correlation between antibody titers and clinical status was showed by Høiby et al. [12] , which found lower ventilatory function, severe radiographic alterations and worst prognosis associated with high P. aeruginosa precipitin levels. Brett et al. [17] observed a correlation between worst ShwachmanKulczyky and Chrispin-Norman scores and enhancement of IgG antibodies against P. aeruginosa in intermittent and chronic patients. West et al. [22] performed chest radiographies at each six months for children under 3 years old and annually for children above 4 years old. Evidences of irreversible lung injuries occurred until 5.8 months before the first positive culture, period that was similar to the appearance of anti-ExoA antibodies.
Antibody response against the infection treatment
Brett et al. [14] observed a considerable variation in IgG titers among CF patients, which decreased after i.v. antibiotic Table 1 Study index, according to author, design, local, objective and results obtained.
therapy. In another study [17] , there was a significant decrease in patients in which antibiotic therapy was well succeeded. Of 15 patients who received i.v. antimicrobial therapy, in 5 bacterial eradication and return of the antibody titers to the normal values were observed, while in 10, continuous isolations occurred, besides partial decrease of the titers. Johansen et al. [23] found a decrease in the precipitin levels during the period of most intensive i.v. antibiotic therapy regimens, and considerably enhanced survival (after the acquisition of chronic infection). Ratjen et al. [29] , with a longitudinal evaluation of antibody titers, before and after inhalatory antibiotic therapy in patients with the first P. aeruginosa isolate, showed a significant reduction in the titers of patients clearing P. aeruginosa infection, while there was increased titers in patients in which eradication therapy failed. Just one study [15] did not observe significant decrease in antibody titers after antibiotic therapy against the evaluated antigens.
Accuracy
Eight studies evaluated the accuracy of serology (ELISA) for different antigens in regard to different patterns used (Table 4) .
Pedersen et al. [16] , evaluating 243 patients, found a sensitivity of 93% and specificity of 92% for ELISA when compared to CIE, obtaining a correlation among results of both methods. In advanced stages of infection, the sensitivity was 90% and the specificity was 100%. Kappler et al. [25] , in a prospective study with 183 negative cultured, intermittent and chronic patients, reported that the antibody detection against three antigens (ExoA, ELA, AP) resulted in a sensitivity of 86%, specificity of 96% and PPV of 97%, in regard to microbiologic culture. Tramper-Stranders et al. [26] studied 67 patients chronically infected, 60 intermittently colonized and 93 non-colonized with P. aeruginosa. The ELISA tests (ExoA, ELA, and AP) using advised cut-off values had a sensitivity of 79% and a specificity of 89% for chronic colonization. Applying new ROC curves to optimize the cut-off values, they obtained a sensitivity of 96% and a specificity of 79% (when all three antigens were evaluated together).
Ratjen et al. [29] , studying the response to ExoA, ELA, and AP in 375 patients (and a cohort of 56 patients under antibiotic therapy), observed individual variability in the antibody titers against ExoA, ELA and AP, with good sensitivity and specificity for all the three antigens. Pressler et al. [32] , for the first time, evaluated the three serological methods most used in the CF follow-up routine and their usefulness in early chronic P. aeruginosa detection. They studied 381 patients free of infection, 129 intermittent colonized and 281 chronically infected. The values encountered showed high sensitivity, specificity, PPV and NPV (about 90%) for all methods. Douglas et al. [34] compared two serological methods (anti-IgG ELISA of the Copenhagen group and an anti-ExoA in-house ELISA) between two CF populations in Australia. They observed high PPVs, but low NPVs in both populations, in regard to BAL culture (used as gold standard in the study) -respectively, 14% and 26% for the St-Ag:1-17 and 11% and 19% for ExoA.
Anstead et al. [35] found a varied accuracy employing five different serological methods for antibody research in a multicenter study, obtaining good results of specificity and NPV, despite of oscillating PPV and sensitivity, different from those of Doğru et al. [37] who found high PPV, NPV and sensitivity of serology to ExoA, ELA and AP, but a high number of patients with negative culture presenting high antibody titers, resulting in low specificity.
Discussion
This review gathered studies for a period of almost 40 years and evaluated the utility of the antibody detection against P. aeruginosa antigens, a technique that has been studied as an alternative to the current gold standard [35] , the culture of respiratory samples, which many times is performed through oropharyngeal swab and has several limitations [19] , such as no representative samples and occurrence of false-negative results. This makes it crucial to detect early this bacteria in order to avoid chronic infection and the resulting infection progress [38, 39] .
Infection is commonly distinguished from colonization based on immune and inflammatory responses, despite of inflammatory response being common in CF. P. aeruginosa isolation in respiratory samples does not necessarily indicate infection unless there is a specific antibody response [20] .
There is a great diversity of results in the studies analyzed herein due to different methodologies, casuistries, times of follow-up, and antigens used. Several studies highlight the importance of the potential diagnostic value of antibody measure for early P. aeruginosa detection, before microbiological culture, in a time period varying from 5 to 30 months [17, 22, 27, 31] . The emergence of the immune response differs according to each employed antigen, being the response to TTSS proteins apparently earlier during the acute stage of infection, declining as the infection progresses to the chronic stage [21, 24] . The response to commercialized antigens (ExoA, ELA and AP -M15 Mediagnost and St-Ag:1-17 -Statens Serum Institute) showed good sensitivity and specificity [16, 25, 26, 29, 32] . The response to St-Ag:1-17 occurred several months before the first microbiological isolation, and the response to ExoA, ELA and AP Precipitates resulting from the antigen-antibody interaction Precipitins occurred several months after the response to St-Ag:1-17, since they are antigens regulated by quorum-sensing, i.e., need a higher microorganism density to lead to the response [13, 32, 40] . Antibodies to ELA appeared later (a mean of 41.1 months after the first microbiological isolation), being more frequent in chronic infected patients, and may be useful in the diagnostic of chronic infection [22, 27] . The enhancement of antibodies against ExoA and AP was associated with the risk of recurrent P. aeruginosa isolation, so patients with new acquisition of the pathogen may benefit from a close monitoring of these antibodies [35] . In some cases, antibody response can be transitory and, especially in children between 4 and 6 years, only one positive result may not represent chronic infection or intermittent colonization [26] . Da Silva Filho et al. [30] tested serology for ExoA, ELA, and AP, and compared it to PCR and microbiological culture, finding that the association of the three methods guided to the higher positivity percentage, being PCR the one with higher positivity, but with no statistical significance. As the study was not longitudinal, they could not take any other conclusions, despite considering that serology should not be useful to detect intermittent colonization cases, since the immune response appears just in persistent or recurrent infection cases. Douglas et al. [34] questioned the use of serology for P. aeruginosa detection, but recognized that they used BAL culture as the gold standard, and this method may lead to false positive results due to contamination of upper airways and false negatives, resulting from inappropriate samples [7] . In general, good accuracy measures are shown by most studies, being serology for antibody detection recommended as a diagnostic tool in the follow-up routine. It is recommended, for non-colonized patients (in the microbiological point of view), that the antibody monitoring be performed at least annually for patients with negative culture and more frequently for intermittent patients [25, 27] . It is observed that there is a relationship between enhanced antibody titers against P. aeruginosa antigens (St-Ag:1-17 [12] , cell wall antigens [17] and ExoA [22] ) and clinical status, where patients presented lower ventilatory function, worst Shwachman-Kulczyki score and severe radiographic alterations, even in a period of almost 6 months before the first positive P. aeruginosa culture [22] , which is associated with the worst prognosis and deterioration of pulmonary function [41] . There is a proposal to associate the X-ray score and antibody titers for the early diagnosis of P. aeruginosa infection [22] . Pressler et al. [32] compared two ELISA tests to distinguish between intermittent colonization and chronic infection. Patients with intermittent culture and higher antibody titers against the St-Ag:1-17 may be indicative of status change to chronically infected, being this response earlier than to ExoA, ELA, and AP. Culture limitations can make it difficult to identify chronically infected patients, which, without immunological results, can be wrongly classified as intermittent or even free of infection or never colonized [9, 30, 32] .
With regard to the response of antibody titers against infection treatment, there was decreasing IgG titers to cell wall antigens and to St-Ag:1-17 after i.v. [14, 17, 23] , and inhalatory [29] antibiotic treatments, with survival of patients who presented lower titers being longer, in chronic infection cases [23] , and enhanced titers in patients in which eradication therapy failed [29] . When there is a rise in the antibody titers, early antibiotic treatment must be considered, since in 80% of the cases it is possible to prevent chronic infection [21, 29, 32, 42] . However, there is a greater consensus that serology results must be confirmed by a longitudinal follow-up, employing other auxiliary diagnostic resources, and thus, should not be adopted as the only criterion for diagnosis and treatment [28, 30, 31, 33, 43] .
Conclusions
Although we found a low number of papers addressing the diagnostic utility of detection of serum antibodies to P. aeruginosa, we recognized consistent results, especially in the studies using the serology for antibody detection against St-Ag:1-17, since the researches employing this antigen had continuity over the course of 30 years, with significant casuistries and early P. aeruginosa detection, with good clinical correlation when compared with longitudinal microbiological culture (prospective microbiological analysis). We also highlight the utility of the ELISA technique for anti-pseudomonal antibodies, which is a simple and commercially available method and does not demand great investments. The accuracy values (sensitivity, specificity, PPV and NPV) of the ELISA technique remain controversial, because of the diversity of antigens, cut-off values and casuistries employed; however, considering that most studies showed a good correlation between anti-pseudomonal antibody titers and clinical status, both for success in eradication and for progress to chronic infection or exacerbations, this resource may be useful in early detection or to alert the clinician to seek for other evidences of P. aeruginosa colonization or infection, and also to provide parameters to evaluate the colonization/infection status [44, 45] . An important gap is the lack of studies comparing serology, microbiological culture and molecular resources for search of evidences of P. aeruginosa presence, like PCR and RT-PCR of respiratory samples, mainly in longitudinal studies with significant casuistries, to better elucidate some apparently inconsistent results of serology. The evidences of potential utility of P. aeruginosa serology, technical and financial viability, give support to suggest the incorporation of this diagnostic tool in the follow-up routine of CF patients in the effort to reduce the prevalence of chronic P. aeruginosa infection and for best understanding of the colonization/infection process.
